Healthcare
Green Thumb Industries Inc.(GTBIF)
Live Price
Offline$7.65
+0.00% today
1Y Change
+50.29%
Window
Jun 25, 2025 โ Jun 15, 2026
- Market Cap
- $1.90B
- Revenue Growth
- +3.4%
- EPS Growth
- +58.1%
- Dividend Yield
- 0.0%
Coverage: 245 bars ยท Jun 25, 2025 โ Jun 15, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Green Thumb Industries Inc. (GTBIF) is a Healthcare stock with a market cap of $1.90B and listed on OTC. The stock last traded around $7.65 and up 50.3% across the available one-year price window (Jun 25, 2025 โ Jun 15, 2026). Baseline metrics include revenue growth of +3.4%, EPS growth of +58.1%, a dividend yield of 0.0%. What stands out right now is revenue +3.4%, EPS +58.1%, free cash flow +86.0% with operating margin 11.7% and ROIC 2.3%. Valuation is more restrained than many high-expectation growth names at P/E 16.3 and price/sales 1.6. Stock Foundry combines GTBIF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
+3.4% vs +7.6% peer median
Operating Margin
Below sector median
+11.7% vs +19.4% peer median
P/E
Below sector median
16.3 vs 36.3 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 6, 2026, but the surprise data is still limited.
The operating story is still moving forward
Revenue is running at +3.4% and EPS at +58.1%, with operating margin around 11.7%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged -3.0% over the next 5 trading days and finished higher after 1 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 6, 2026 | โ | -2.9% | -9.7% | -2.4% |
2026 Feb 25, 2026 | +2645.1% | -0.3% | -1.5% | -3.8% |
2025 Nov 5, 2025 | +33.3% | -5.0% | +2.2% | -0.3% |
Benchmark Edge
GTBIF vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
GTBIF
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
GTBIF Max Drawdown
-41.91%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for GTBIF and SPY.
Company Overview
Green Thumb Industries Inc.
Other OTC
Green Thumb Industries Inc. engages in manufacture, distribution, and sale of various cannabis products for medical and adult-use in the United States. It offers cannabis flower; and processed and packaged products, including pre-rolls, concentrates, vapes, tinctures, edibles, topicals, and other cannabis-related products under the Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles, and RHYTHM brands. The company distributes its products primarily to third-party retail stores, as well as sells finished products directly to consumers in its own retail stores. As of April 11, 2022, it owned and operated 77 retail stores in the United States. The company was founded in 2014 and is headquartered in Chicago, Illinois.
- Leadership
- Benjamin Kovler
- IPO Date
- Jun 14, 2018
- Employees
- 4.9k
- Street Address
- 325 West Huron Street
- Mailing
- Chicago, IL, 60654
- Region
- Chicago, IL, US
- Reporting Currency
- USD
- Investor Line
- 312 471 6720
- Last Updated
- Apr 29, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 16.3
- EV/EBITDA
- 6.5
- Price/Sales
- 1.6
- Price/Book
- 1.0
Growth
- Revenue
- +3.4%
- EPS
- +58.1%
- Free Cash Flow
- +86.0%
Profitability
- Gross Margin
- 47.5%
- Operating Margin
- 11.7%
- Net Margin
- 9.8%
- ROE
- 6.3%
- ROIC
- 2.3%
Balance Sheet
- Debt/Equity
- 0.41
- Current Ratio
- 3.26
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.